Gradientech’s Nomination Committee for the 2023 Annual General Meeting

The Nomination Committee for Gradientech AB prior to the 2023 Annual General Meeting has been appointed based on the ownership structure as of August 31, 2022.

The Nomination Committee consists of:

  • Henrik Didner, representing Monesi Förvaltnings AB
  • Allan Asp, representing Almi funds
  • Andy Browning, nominated by Sara Thorslund and Johan Kreuger
  • Mikael Lönn

The shareholders who have appointed members to the Nomination Committee together represent approximately 26 percent of the voting rights for all shares in Gradientech AB.

The annual general meeting in Gradientech AB will be held on Wednesday May 10, 2023. Shareholders who wish to submit proposals to the Nomination Committee can do so via e-mail to ir@gradientech.se or by letter to:

Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

In order for proposals to be processed by the Nomination Committee, they should be received by 31 January 2023 at the latest.

For more information please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala


About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book